Beta-blocker therapy and physical activity after myocardial infarction: a preplanned sub-study of the BETAMI trial

Authors:

Abstract
Aims: To investigate the effect of long-term beta-blocker therapy on physical activity (PA) level after myocardial infarction (MI) in patients without heart failure. Methods and results: The BETAMI trial randomized patients hospitalized with a MI without heart failure (LVEF ≥40%) to beta-blocker or no beta-blocker. In this preplanned sub-study, PA level was assessed by guideline-recommended PA level (≥30 min moderate activity ≥5 days/week) or not and self-reported hours/week with light to moderate and vigorous PA. Between-group differences in PA from baseline before randomization to 18-months were estimated by linear mixed models. Exploratory analysis assessed treatment effects on a composite of all-cause mortality and major adverse cardiovascular events using a Cox proportional hazards model. Of the 2867 randomized patients, 2185 (76%) responded to the PA questions and were included in this analysis. Mean age was 62.5 (SD 10.1) years, and 20.6% were women. No differences in guideline-recommended PA level or mean hours of light to moderate and vigorous PA were reported between the beta-blocker and non-beta-blocker group at baseline or during 18-month follow-up. At 12-month follow-up, 37.0% in the beta-blocker group and 36.7% in the no beta-blocker group reported guideline-recommended PA level (OR 0.97, 95% CI 0.69–1.37). Exploratory, hypothesis-generating analyses did not demonstrate a statistically significant interaction (P for interaction = 0.06) between treatment assignment and baseline PA level for recurrent clinical events. Conclusion: Beta-blocker therapy did not result in a change in PA level in post-MI patients without heart failure during the 18-month follow-up. Registration: ClinicalTrials.gov. URL: https://clinicaltrials.gov/search?term==NCT03646357. Unique identifier: NCT03646357, registered on 23 August 2018.
Funding Information
  • Health South-East research program (2017205)
  • Norges Forskningsråd (302454)

This publication has 27 references indexed in Scilit: